![]() | ClinTex |
ClinTex is delivering intuitive blockchain-based platform solutions to deliver self-service analytics solutions to the pharmaceutical industry.
Important By investing in this business you agree to ourDisclaimer. All information including our rating, is provided merely for informational purposes. CryptoTotem does not provide investment advice.
What is ClinTex
ClinTex CTi is a blockchain-based solution designed for clinical trial management. The CTi platform will function as a decentralized database for clinical data and host 7 separate DApps that are supposed to streamline clinical trial process with the help of AI. The solution will provide various features such as clinical data visualization, clinical data management tools, predictive analytics, etc.
The platform will employ a native ERC20 CLX token. It will be used to access various levels of data analytics and execute payments.
ClinTex Roadmap
CTi Data Model Design;
CTi-OEM Prototype Development.
Pre Sale TGE;
Public TGE.
CTi GUI Development (with Integrated CLX Wallet);
Blockchain Verification of CTi Pre-Processing Data.
Blockchain Verification of CTi Pre-Processing Data;
CTi-OEM DEvelopment.
CTi-PDA Development.
CTi-PRR Development;
Migration on-chain of CTiClinical Data Statistical Summaries.
CTi-RBM Development;
CTi-CDV Development.
Cti-VMM Development.
CTi-SIM Development.
Migration on-chain of the CTi Data Model and CTi Processing Engine,
Token Allocation
Funding Details
Token distribution
35% - Token Generation Event
15% - Token Generation Event Pre-Sale
10% - Strategic Partners Private Sale
10% - Management Team
10% - Shareholders
10% - Team Incentive (Milestone Based Structured Bonus Scheme)
4% - Reserved for Advisors
3% - Reserved for Referrals, Promotions & Bounty
3% - Reserved for Pharma Industrial Trials (Testing)
Funds allocation
35% - platform development (blockchain developers, machine learning and neuro-linguistic programming experts, web and software developers)
30% - Clinical and analytic development (data scientists, statisticians, etc.)
2% - ClinTex Research Grants to fund collaboration on clinical trials with NHS trusts, Universities and the Institute of Translational medicine
15% - Marketing & sales, business growth and development
10% - Legal and accounting expenses, monitoring and assurance of compliance to FDA regulations (21 CRF part 11 compliance)
8% - Operational expenses (admin / HR / rent, utilities, etc.)
Token Price and Payment Options
Project team



















Advisors

















